Low-Frequency Vibrations Enhance Thrombolytic Therapy and Improve Stroke Outcomes

Area of Science:

• Neurology
• Biomedical Engineering
• Pharmacology

Background:

• Helicopter transport for stroke thrombolysis involves low-frequency vibrations (LFVs).
• The impact of LFVs on thrombolytic therapy efficacy is not well understood.

Purpose of the Study:

• To investigate the effect of helicopter-induced LFVs on stroke thrombolysis using recombinant tissue-type plasminogen activator (rtPA).
• To assess the safety and efficacy of LFVs as an adjunct to rtPA treatment in a mouse model.

Main Methods:

• Mice with induced middle cerebral artery occlusion received rtPA or saline.
• Treatment was administered under simulated helicopter LFV, actual helicopter flight, or ground control conditions.
• Infarct volume and neurological outcomes were measured.

Main Results:

• Simulated LFVs significantly reduced infarct size and improved neurological outcomes in mice receiving rtPA.
• Actual helicopter flight conditions did not yield the same benefits, potentially due to vibration attenuation.
• LFVs alone did not affect outcomes in saline-treated mice, and blood-brain barrier permeability remained intact.

Conclusions:

• Low-frequency vibrations (0.5-120 Hz) are synergistic with rtPA, enhancing thrombolysis efficacy.
• LFVs represent a novel, safe, and easily implementable intervention to potentially improve stroke patient outcomes.
• Further research is warranted to optimize LFV parameters for clinical application.